Researcher
Liesbeth Lenaerts
- Disciplines:Paediatrics and neonatology not elsewhere classified, Gynaecology and obstetrics not elsewhere classified, Cancer diagnosis, Oncology not elsewhere classified
Affiliations
- Gynaecological Oncology (Division)
Member
From1 Sep 2015 → Today - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 2002 → 23 Dec 2011
Projects
1 - 4 of 4
- Towards a better understanding of incidental cancer detection upon non-invasive prenatal testingFrom17 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Evaluation of chemotherapy-associated fetal damage in cancer in pregnancyFrom1 Sep 2019 → TodayFunding: FWO fellowships, Foundations, funds and other with scientific goal
- Postpartum breast cancer diagnosed during the post-weaning period: a distinct entity with unique clinicopathological, molecular and immunological features?From22 Sep 2015 → 9 Jan 2023Funding: Private funding of national origin - undefined
- Identification of the mouse adenovirus type 1 receptor and evaluation of its potential for human gene therapy.From1 Jan 2009 → 22 May 2010Funding: BOF - Other initiatives
Publications
1 - 10 of 33
- Comprehensive Recommendations for the Clinical Management of Pregnant Women With Noninvasive Prenatal Test Results Suspicious of a Maternal Malignancy.(2024)
Authors: Liesbeth Lenaerts, Frédéric Amant, Miel Theunis, Joris Vermeesch
Pages: OP2300594 - Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study.(2024)
Authors: Bernard Thienpont, Kristel Van Calsteren, Liesbeth Lenaerts, Frédéric Amant
Pages: e081833 - Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology.(2024)
Authors: Tatjana Jatsenko, Stefania Tuveri, Lore Lannoo, Kristel Van Calsteren, Liesbeth Lenaerts, Sabine Tejpar, Bernard Thienpont, Joris Vermeesch
Pages: 2220 - MetDecode: a novel methylation-based method for cell-free DNA tissue-of-origin assignment(2024)
Authors: Antoine Passemiers, Liesbeth Lenaerts, Joris Vermeesch
Pages: 611 - 611 - Non-invasive prenatal testing: when results suggests maternal cancer(2023)
Authors: Liesbeth Lenaerts, Miel Theunis, Frédéric Amant, Joris Vermeesch
Pages: 285 - 295 - Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features(2023)
Authors: Beppe Floris, Kristel Van Calsteren, Patrick Neven, Sileny Han, Daniela Annibali, Diether Lambrechts, Liesbeth Lenaerts, Frédéric Amant
Pages: 3729 - 3743 - Single-cell evaluation of DNA damage in offspring after prenatal exposure to chemotherapy(2023)
Authors: Kristel Van Calsteren, Lode Godderis, Liesbeth Lenaerts, Frédéric Amant
Pages: 68 - 68 - Noninvasive prenatal screening and maternal malignancy: role of imaging.(2023)
Authors: Liesbeth Lenaerts, Joris Vermeesch, Frédéric Amant
Pages: 1590 - 1598 - Postpartum breast cancer diagnosed during the post-weaning period: a distinct entity with unique clinicopathological, molecular and immunological features?(2023)
Authors: Hanne Lefrere, Frédéric Amant, Diether Lambrechts, Liesbeth Lenaerts
- Characterization of the genotoxic profile of antineoplastic drugs using the cytokinesis-block micronucleus cytome assay(2023)
Authors: Ilana Struys, Eline Verscheure, Liesbeth Lenaerts, Frédéric Amant, Lode Godderis, Manosij Ghosh